Fort mafi kyau, tx, 2 ga Agusta, 2022 (Dorbon Newswirection kayayyaki, a yau ya sanar da cewa zai sake samar da kudi na biyu kwata na Alhamis. Agusta 11, 2022, a kusantar kasuwannin Amurka.
Gudanarwa za su rike kiran taro a karfe 4:30 na yamma et don tattaunawa game da sakamakon kuɗi kuma samar da sabuntawa kan kamfanoni da ci gaba.A gabatarwar Q & wani zaman tare da masu saka jari.
Kamfanin zai kira kiran taro a ranar Alhamis, 11 ga Agusta, 2022 da karfe 4:30 na PM et don sake bita a asibiti, kamfani da aikin kuɗi. Don shiga cikin taron, shiga cikin gidan yanar gizo ko kiran waya ɗaya daga cikin masu zuwa kafin fara kiran:
Hakanan ana iya samun gidan yanar gizo mai rai kuma ana iya samun dama a shafin yanar gizon SPF Pharmaceuticals, https://tfforme.com ko kai tsaye a https :/starshels.com/strasei Hakanan ana iya samun gidan yanar gizo mai rai kuma ana iya samun dama a shafin yanar gizon SPF Pharmaceuticals, https://tfforme.com ko kai tsaye a https :/starshels.com/strasei Онцеренцияовет Транся втире Вть иатомпна оступна соступна ноступна соступна соступна соступна соступна Сайтьпна найтьпо Diеоооосредствено на Htttps://viavid.wiavid.Weide.jspei=1558913&Tp_Key=3745453C47. Hakanan za a sake taron ya rayu kuma ana samun su a kan shafin yanar gizon TFFPTPS na HTFPS ://viavid.wivid.Jibcast.kple.kp电话会议还将进行网络直播, 网 Taff Pharpeutps 的 或直接访问 https.Wiavid.Jibcast.kp comtp_Key=374545337 访问. 的f 网 ا https://tfframa.com 或直接访问 https.wiavid.wivid.Jibcast.Jaspei=1558913&tp_KEY34=33 Онференц-свя Zaaninовярранся вотернернернернернернернернернернернернернернернернернернернернернернернернернернернернернернернерне Aапряпряпресу https://viavid.wiavid.webcasts.com/startherei=1558913&tp_Key=4345453c47. Kira taron taron zai zama gidan yanar gizon yanar gizo kuma zai kasance a shafin yanar gizon SPRMaceuticicals a htfps://tfformer.kepcors.com/stras.kei=1558913&tp_Key=37.Da fatan za a ziyarci shafin yanar gizon kamfanin akalla mintina 15 kafin nadin ku don yin rajistar, saukarwa da shigar da duk software ta Audio da ake buƙata. Hakanan za'a buga kiran a cikin watan a cikin kalandar masu saka hannun jari na shafin yanar gizon kamfanin.
Game da Tf Pharty Pharmaceuticals bakin fim daskarewa TFF PRACETMaceuticals 'Hff) Fasaha na Bashi Tsarin daskarewa fim ne tsari na injiniya wanda aka tsara don samar da busasshiyar barbashi tare da kayan kwalliya na al'ada don inhalation. Ana iya amfani da wannan tsari don haɓaka powders don isar da kai zuwa shafin da ake so, da hakan yana hana yin aiki da inganci da inganta aminci da inganci. Ikon isar da maganin kai tsaye don niyya kwayoyin kamar yadda huhu ya ba da damar Tffder foda da za a gudanar da su na baka da wahala da sakamako masu illa. Bayanan dakin gwaje-gwaje suna nuna cewa kaddarorin Aerdodnamic na bakin ciki-fim daskararre na iya isar da kashi 75% na kashi zurfi cikin huhu. Maimakon bayyanar zafi, karfi damuwa, ko wasu sojojin da zasu iya lalata waɗannan kayan aikin da suke da sauƙin adanawa da kuma rigakafin da za a rarraba su da yawa a duniya. . Za'a iya amfani da fa'idodin daskarewa na bakin ciki don inganta isar da al'adun gargajiya ko a haɗe tare da tsararren talakawa.
Game da Tf Phar Farmmaceuticals, Inc. Shin wani kamfani ne na asibiti tsararren kamfanin da ke amfani da shi da canza magunguna masu tasiri, aminci da kwanciyar hankali. Kayan fim din na kayan kwalliya na kamfani (Tff) dandamali na fasaha yana da aikace-aikace mai yawa kuma yana da manyan kwayoyin, a cikin magunguna bushe, saboda haka ana iya isar da miyagun ƙwayoyi. A cikin idanu, hanci da fata na gida. TFF tana da manyan 'yan takarar magunguna guda biyu, Voriconazole Inuwa foda da Taclolimus Inhickcaller foda, kuma yana ci gaba da fadada lafiyar kamfanonin masana'antu, cibiyoyin ilimi da abokan ilimi. An gabatar da dandamali na TFF da sama da sama da 120 aka bayar ko kuma a yayin Amurka da wasu ƙasashe. Don ƙarin koyo game da Tafdar FAFFACETICEUTICICES da samfuran ɗan takarar, ziyarci shafin yanar gizon kamfanin a https://tffrma.com.
Lafiya mai aminci wannan sakin ya ƙunshi maganganun na gaba game da Tackmaceticalus, Inc., CIGABA DA GASKIYA Tacrolimus, fa'idodin kamfanin Tacf Powers, da shirin kamfanin ya kara zuwa layin samfurin dan takarar data kasance. Wadannan kalamai na gaba sun hada da hadarin da aka sani da ba a sani ba, rashin tabbas da sauran dalilai da zasu iya haifar da sakamako na musamman don bambanta abubuwa. Waɗannan abubuwan sun haɗa da: (i) Hadarin da Kamfanin ba zai iya samun nasarar kammala gwajin kasuwanci ba ko kuma a halin yanzu da ya sami yarjejeniya da ta hanyar sha ko fahimta da kowane babban kamfanin kasuwanci zuwa Haɓaka magani don haɗawa a cikin tsarin Tff, (IV) Kamfanin ba zai iya shiga yarjejeniyoyi na kasuwanci na dogon lokaci tare da kowane ɓangare na uku ba; Kuma (v) wasu haɗarin da aka gano a cikin "abubuwan hadarin" na samar da rahoton shekara 10, 2022. Tff Pharmaceuticals yana ɗauka kuma yana nuna takamaiman kowane wajibi don sabuntawa ko bita da irin waɗannan maganganun don nuna sabbin yanayi ko doka ta buƙata.
TFF Pharmaceuticals Investor Relations Contact: Corey Davis, PhD LifeSci Advisorsscdavis@lifesciadvisors.com 212-915-2577
TFF Pharmaceuticals Media Contact: Gwendolyn SchankerLifeSci Communications(269) 921-3607gschanker@lifescicomms.com
Lokaci: Aug-10-2022